32 results on '"Guadalupi, Livia"'
Search Results
2. Pharmacological blockade of 2-AG degradation ameliorates clinical, neuroinflammatory and synaptic alterations in experimental autoimmune encephalomyelitis
3. BACE1 influences clinical manifestations and central inflammation in relapsing remitting multiple sclerosis
4. Re-emergence of T lymphocyte-mediated synaptopathy in progressive multiple sclerosis
5. Interleukin-10 contrasts inflammatory synaptopathy and central neurodegenerative damage in multiple sclerosis.
6. Exercise protects from hippocampal inflammation and neurodegeneration in experimental autoimmune encephalomyelitis
7. Re-emergence of T lymphocytemediated synaptopathy in progressive multiple sclerosis.
8. MiR-142-3p is a Critical Modulator of TNF-mediated Neuronal Toxicity in Multiple Sclerosis
9. Low-contrast visual acuity test is associated with central inflammation and predicts disability development in newly diagnosed multiple sclerosis patients.
10. Pharmacological blockade of 2-AG degradation ameliorates clinical, neuroinflammatory and synaptic alterations in experimental autoimmune encephalomyelitis
11. Distinct intrathecal inflammatory signatures following relapse and anti-COVID-19 mRNA vaccination in multiple sclerosis
12. Distinct intrathecal inflammatory signatures following relapse and anti- COVID-19 mRNA vaccination in Multiple Sclerosis. A cross-sectional study.
13. Preventive exercise attenuates IL-2-driven mood disorders in multiple sclerosis
14. Interleukin 6 SNP rs1818879 Regulates Radiological and Inflammatory Activity in Multiple Sclerosis
15. The BDNF Val66Met Polymorphism (rs6265) Modulates Inflammation and Neurodegeneration in the Early Phases of Multiple Sclerosis
16. Neuroinflammation Is Associated with GFAP and sTREM2 Levels in Multiple Sclerosis
17. MiR‐142‐3p regulates synaptopathy‐driven disease progression in multiple sclerosis
18. The microRNA let-7b-5p Is Negatively Associated with Inflammation and Disease Severity in Multiple Sclerosis
19. Corrigendum: Inflammation-Associated Synaptic Alterations as Shared Threads in Depression and Multiple Sclerosis
20. MiR‐142‐3p regulates synaptopathy‐driven disease progression in multiple sclerosis.
21. Re-Examining the Role of TNF in MS Pathogenesis and Therapy
22. Emerging Role of Extracellular Vesicles in the Pathophysiology of Multiple Sclerosis
23. Inflammation-Associated Synaptic Alterations as Shared Threads in Depression and Multiple Sclerosis
24. Central Modulation of Selective Sphingosine-1-Phosphate Receptor 1 Ameliorates Experimental Multiple Sclerosis
25. ‘Prototypical’ proinflammatory cytokine (IL-1) in multiple sclerosis: role in pathogenesis and therapeutic targeting
26. Tumor Necrosis Factor and Interleukin-1β Modulate Synaptic Plasticity during Neuroinflammation
27. Immunomodulatory Effects of Exercise in Experimental Multiple Sclerosis
28. Voluntary running wheel attenuates motor deterioration and brain damage in cuprizone-induced demyelination
29. Transient Receptor Potential Vanilloid 1 Modulates Central Inflammation in Multiple Sclerosis
30. Interplay Between Age and Neuroinflammation in Multiple Sclerosis: Effects on Motor and Cognitive Functions
31. BACE1 influences clinical manifestations and central inflammation in relapsing remitting multiple sclerosis
32. Distinct intrathecal inflammatory signatures following relapse and anti-COVID-19 mRNA vaccination in multiple sclerosis.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.